LAVAL, Quebec — Bausch + Lomb, a wholly-owned subsidiary of Valeant Pharmaceuticals International, is introducing Ocuvite Blue Light eye vitamins, a nutritional supplement formulated with lutein and zeaxanthin, the two carotenoid pigments naturally found in the eye.
The company said this formulation of eye nutrients includes high levels of lutein and helps protect eyes from the blue light that reaches the macula, which is responsible for the central vision.
“With the increasing number of hours Americans are spending on digital devices, there is a growing need for a product that helps our eyes filter the blue light that is emitted from these devices,” said Joseph Gordon, president of consumer healthcare and vision care for Bausch + Lomb. “Ocuvite Blue Light is specifically formulated to meet this need and help consumers maintain their eye health in our screen-centric world.”
The company said most adults spend seven or more hours daily in front of digital devices, exposing themselves to blue light for an extended period of time, and added that reducing their exposure to blue light can support their eye health.
Ocuvite Blue Light eye vitamins contain 25 milligrams of lutein and five milligrams of zeaxanthin isomers, the key eye nutrients that help absorb blue light before it reaches the macula.
Ocuvite Blue Light eye vitamins will be available for purchase in the vitamin and eye care aisles at major retailers in the third quarter of 2018 and will sell for a suggested $16.99.